Spirita Oncology Initiated Global Clinical Development of E6201 in Collaboration With JS ...
Medical Health News,
BOSTON--(BUSINESS WIRE)--Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Shan…
BOSTON--(BUSINESS WIRE)--Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Shan…
Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Shanghai) Ltd.
BOSTON--(Business Wire)--Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Shan…
Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Shanghai) Ltd.
BOSTON--( BUSINESS WIRE )--Spirita Oncology, LLC, announced that it has entered into a sublicense agreement with JS Innopharm (Sh…